Funding profile · Life sciences software

Argon AI

One Form D, filed in June 2024, reports an offering of $5,515,000 offered and sold in full to 31 investors. The company announced that money as a $5.5 million seed round thirteen months later. Nothing has been filed since.

$5.52MOffered and sold in full, Form D filed Jun 13, 2024
31Investors in that offering, none non-accredited
$178KAverage per investor, amount sold divided by investor count
13 moFrom the Form D filing to the public funding announcement

Data as of September 23, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Winter 2024 Y Combinator batch Not disclosed Y Combinator YC data
May to Jun 2024 Equity offering, Rule 506(b) $5,515,000 offered, $5,515,000 sold 31, not named in the filing Form D
Jul 2, 2025 Seed, as announced $5.5M Co-led by Crosslink Capital and Wireframe Ventures; Y Combinator, Pioneer Fund, unnamed others Company release
To Sep 23, 2026 No later offering on file None None SEC EDGAR

What the filings show

Argon AI, Inc. · Form D · filed Jun 13, 2024

First sale
May 31, 2024
Offered
$5,515,000 equity
Sold
$5,515,000 · $0 remaining
Investors
31 · average about $177,900
Non-accredited
None
Exemption
Rule 506(b)
Sales compensation
None reported · finders fees $0 · nothing to officers
Related persons
Samyar Danesh Bahreini (executive officer, director, promoter); Cyrus Jia (executive officer, director)
Issuer
Delaware corporation, incorporated 2023 · Brooklyn, NY · industry given as Other Technology · revenue range: Decline to Disclose
Filing
SEC EDGAR, CIK 0002026471

Reading the filings

  1. The round was closed before it was announced.First sale May 31, 2024; filed June 13, 2024; sold in full at filing with $0 remaining. The press release went out July 2, 2025. Thirteen months separate the money from the announcement, which is legal and common, and it means the July 2025 coverage describes capital that had been committed for over a year.
  2. The filed number and the announced number match.$5,515,000 rounds to $5.5 million. Most companies announce a headline figure larger than the Form D, or file an amendment after further sales. Argon did neither. The seed round is one offering, taken down in full, and the public figure is accurate rather than rounded up.
  3. The average check is angel sized, not fund sized.$5,515,000 across 31 investors is about $177,900 each. A round co-led by two venture firms with 31 participants implies two institutional checks plus a long tail of individuals and small vehicles. The release refers to other investors beyond the four it names, and the filing names none of them.
  4. No investor sits on the filing.Related persons are the two founders only, Samyar Danesh Bahreini and Cyrus Jia. A Form D lists directors, so a $5.5 million co-led round left the board with no outside seat as of June 2024. Whether one was added later is not visible, because no further filing exists.
  5. One filing since incorporation, and nothing since.Argon incorporated in Delaware in 2023 and has a single Form D under CIK 0002026471. A company can raise under Section 4(a)(2) and file nothing, so silence is not proof that no money moved. It does mean that as of September 23, 2026 there is no reported Series A and no amendment.
  6. Aggregator totals are not supported by the record.At least one startup database reports $12.0M across three rounds, including a $6M round dated June 1, 2024 and a $500K round in April 2024, and attaches investor names that appear in no SEC filing and in no Argon announcement. The June entry sits within days of the actual Form D and its amount is close to it, which is consistent with the same offering being counted twice and then added again to the 2025 announcement of that same money. Treat the $12.0M figure as unverified.

Commercial signals

Signal Detail Source type
Named customer Basis Health, part of Basis Global, announced a firm wide rollout on Sep 23, 2025 and named Argon its generative AI partner. Partner-stated
Unnamed customers Two of the top fifteen global pharmaceutical companies, per the July 2025 release. Neither has been named since. Company-stated
Reported impact 40 to 60 percent less time on intensive manual insight tasks, per the Basis team. No method or baseline published. Partner-stated
Pricing Not published. Enterprise sales motion, contact sales only. Not found
Compliance No SOC 2, HITRUST or ISO 27001 attestation published as of Sep 23, 2026. Not found
Hiring Head of Engineering listed at $200,000 to $400,000 with 0.50 to 10.00 percent equity, in person in New York. The YC profile still records a team size of two. Company listing
Regulated records No FDA, clinical trial, federal grant or PubMed record names the company. Expected for a software vendor. Public record

What to watch

  • A Form D for any offering after June 2024. One is due within 15 days of first sale.
  • An amendment to the 2024 filing, which would be the first sign of an outside director.
  • Named pharma customers, or a second named consultancy of the size of Basis Health.
  • A published security attestation, which enterprise pharma procurement normally requires.
  • Licensing terms for the sell-side analyst research the platform resells access to.

The Argon AI story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Comprehend Systems: Shared investor: Crosslink Capital. A Y Combinator company that sold software for watching clinical trials while they were still running
  • Reverie Labs: Shared investor: Wireframe Ventures. A Cambridge company that used machine learning to design brain penetrant kinase inhibitors for cancer
  • Endpoint Health: Shared investor: Wireframe Ventures. A Palo Alto company that set out to rescue sepsis drugs the field had given up on, by finding the patients they actually help
  • Convexia: Similar focus. A two person, Y Combinator backed startup that wants AI agents to do the job of a pharma business development team: find overlooked drugs, judge them, and eventually

Sources

  1. Public recordForm D, Argon AI, Inc., CIK 0002026471SEC EDGAR · filed Jun 13, 2024
  2. Public recordFDA, ClinicalTrials.gov, NIH RePORTER, NSF and PubMed searches, no record naming the companyUS federal databases · checked Sep 23, 2026
  3. IndependentArgon AI raises $5.5M to build AI-native workspace for biopharma teamsSiliconANGLE, Kyt Dotson · Jul 2, 2025
  4. IndependentArgon AI raises $5.5M for product improvement, team growthMobiHealthNews, Anthony Vecchione · Jul 2025
  5. IndependentArgon AI Raises $5.5 Million in Seed RoundThe SaaS News, Ben Murray · Jul 4, 2025
  6. IndependentBasis Health Taps Argon AI to Cut Consulting Inefficiencies by 40-60%The AI Journal · Sep 23, 2025
  7. IndependentArgon company and product trust profiles, no compliance claims publishedSOTA2 · accessed Sep 23, 2026
  8. CompanyArgon AI Raises $5.5M to Build the AI Workspace Powering the Future of Life SciencesBusiness Wire · Jul 2, 2025
  9. PartnerBasis Health Partners with Argon AI to Build the AI Backbone of Life-Sciences ConsultingWebWire · Sep 23, 2025
  10. CompanyArgon AI, Inc. company profile, launch post and Head of Engineering listingY Combinator · accessed Sep 23, 2026
  11. Differs from the recordArgon AI funding, team and investors listing reporting $12.0M across three roundsStartup Intros · accessed Sep 23, 2026

Compiled from SEC and other public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Argon AI. This page is not an offer to sell or a recommendation to buy any security.